Aveanna posts September 2025 investor presentation

Aveanna Healthcare Holdings Inc. furnished an investor presentation as part of a current report.

(Moderate)

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Aveanna Healthcare Holdings Inc. furnished an investor presentation as part of a current report. On September 29, 2025, the company made a financial presentation available to investors and attached it as Exhibit 99.1 to this report. The presentation is also accessible through the Investors section of Aveanna’s website.

The company explains that it routinely uses its website and investor presentations to share important and time-sensitive information. The materials in this report, including Exhibit 99.1, are designated as “furnished” rather than “filed,” which means they are not subject to certain Exchange Act liabilities and are not automatically incorporated into other SEC filings unless specifically referenced.

8-K Event Classification

Item 7.01 — Regulation FD Disclosure

1 item

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aveanna Healthcare Holdings Inc. (AVAH) disclose in this 8-K?

Aveanna Healthcare Holdings Inc. furnished an investor financial presentation, dated September 2025, as Exhibit 99.1 and made it available to investors and on its website.

How can investors access Aveanna Healthcare (AVAH) September 2025 investor presentation?

Investors can access the Aveanna investor presentation attached as Exhibit 99.1 to this report and through the “Investors” section of the company’s website at www.aveanna.com or ir.aveanna.com.

How does Aveanna Healthcare (AVAH) use its website for investor information?

Aveanna states it uses its website as a channel to distribute important company information, including press releases, investor presentations, and financial information, and may post time-critical updates there in advance of or instead of press releases or SEC filings.

Is the Aveanna (AVAH) investor presentation considered filed with the SEC?

No. The information in Item 7.01, including Exhibit 99.1, is described as “furnished” and not “filed” for purposes of Section 18 of the Exchange Act and is not subject to its liabilities.

Can the Aveanna (AVAH) September 2025 investor presentation be incorporated into other SEC filings?

The company states the furnished information will not be incorporated by reference into other Exchange Act or Securities Act filings unless a later filing specifically incorporates it by reference.

Who signed this Aveanna Healthcare (AVAH) 8-K report?

The report was signed on behalf of Aveanna Healthcare Holdings Inc. by Matthew Buckhalter, Chief Financial Officer and Principal Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 09/29/2025 - 05:15 PM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     Date of Report (Date of earliest event reported): September 29, 2025

    

Aveanna Healthcare Holdings Inc.

(Exact name of Registrant as Specified in Its Charter)


Delaware	001-40362	81-4717209
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

400 Interstate North Parkway SE
Atlanta, Georgia		30339
(Address of Principal Executive Offices)		(Zip Code)

     Registrant’s Telephone Number, Including Area Code: 770 441-1580

    

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	AVAH	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On September 29, 2025, Aveanna Healthcare Holdings Inc. (the "Company", "we", "us", or "our") made available a financial presentation to investors. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at ir.aveanna.com.

Use of our Website and Social Media to Distribute Material Company Information

We use our website as a channel of distribution for important Company information. We routinely post on our website important information, including press releases, investor presentations and financial information, which may be accessed by clicking on the “Investors” section of www.aveanna.com. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the “Investors” section of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when certain new information is made available on our website. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference in this Current Report on Form 8-K.

The information contained in this Item 7.01, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act, except to the extent such other filing specifically incorporates such information by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.


Exhibit Number		Description
99.1		Aveanna Investor Presentation - September 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			AVEANNA HEALTHCARE HOLDINGS INC.

Date:	September 29, 2025	By:	/s/ Matthew Buckhalter
			Matthew Buckhalter Chief Financial Officer (Principal Financial Officer)

Source: View Original Filing on SEC EDGAR